TRANS (+/-) (4-(4-METHYLPHENYL)PYRROLIDIN-3-YL)CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 1g

3-(3-hydroxyquinoxalin-2-yl)propanoic acid, 95.0%, 25g

Methyl (4-cyanophenyl)acetate, 95.0%, 250mg

GC capillary column ROTI®Cap-624, 50 m, 0.32 mm, 1.80 µm, 1 Piece(s)

5-Thiophen-2-yl-isoxazole-3-carboxylic acid, 95.0%, 250mg

methyl 2-amino-4-(2,4-dimethoxyphenyl)thiophene-3-carboxylate, 95.0%, 1g

(1r)-1-(5-Bromothiophen-2-yl)ethan-1-ol, 95%, 500mg

(6-Bromo-4-methyl-pyridin-3-yl)-methanol, 97%, 500mg

(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol with methanesulfonate, 97.0%, 25g

4-Decyloxybenzaldehyde>97.0%(GC)25g

4-(Ethoxymethyl)-2-methoxyphenol>98.0%(GC)5g

5-(2-Nitro-phenyl)-[1,3,4]oxadiazol-2-ylamine, 95.0%, 5g

Bis(4-fluorophenyl)iodonium triflate, 98%, 25g